Brentuximab is a drug indicated for the treatment of cancer, which can be used to treat Hodgkin’s lymphoma, anaplastic lymphoma and white blood cell cancer.
This medicine is an anticancer agent composed of a substance intended to destroy cancer cells, which is linked to a protein that recognizes certain cancer cells (monoclonal antibodies).
Brentuximab is priced between 17,300 and 19,200 reais and can be purchased from pharmacies or online stores.
Under medical advice, the starting dose used is 1.8 mg per 1 kg of weight, every 3 weeks, for a maximum of 12 months, if necessary and according to medical advice, this dose can be reduced to 1.2 mg per kg of weight.
Brentuximab and an intravenous medicine, which should only be administered by a qualified doctor, nurse or health care professional.
Some of the side effects of Brentuximab may include shortness of breath, fever, infection, itching, hives, back pain, nausea, shortness of breath, thinning of the hair, chest cramping, weakening of the hair, muscle pain or changes in blood.test results.
Brentuximab is contraindicated in children, patients treated with bleomycin and patients allergic to one of the components of the formula.
Also, if you are pregnant or breastfeeding or have other health problems, you should talk to your doctor before starting treatment.